Unresolved disorder model. using A ATOM 55 CA AHIS 7 12.547 -8.984 11.947 0.50 26.46 C Unresolved disorder model. using A ATOM 56 CA BHIS 7 12.490 -8.953 11.769 0.50 26.72 C Unresolved disorder model. using A ATOM 59 CB AHIS 7 13.631 -8.917 10.864 0.50 24.02 C Unresolved disorder model. using A ATOM 60 CB BHIS 7 13.178 -8.936 10.366 0.50 26.41 C Unresolved disorder model. using A ATOM 61 CG AHIS 7 14.298 -10.242 10.729 0.50 21.11 C Unresolved disorder model. using A ATOM 62 CG BHIS 7 14.615 -8.991 10.764 0.50 28.28 C Unresolved disorder model. using A ATOM 63 ND1AHIS 7 15.395 -10.649 11.447 0.50 21.79 N Unresolved disorder model. using A ATOM 64 ND1BHIS 7 15.058 -7.915 11.524 0.50 36.43 N Unresolved disorder model. using A ATOM 65 CD2AHIS 7 13.958 -11.261 9.923 0.50 23.24 C Unresolved disorder model. using A ATOM 66 CD2BHIS 7 15.624 -9.848 10.620 0.50 27.44 C Unresolved disorder model. using A ATOM 67 CE1AHIS 7 15.719 -11.874 11.073 0.50 22.57 C Unresolved disorder model. using A ATOM 68 CE1BHIS 7 16.312 -8.144 11.782 0.50 35.95 C Unresolved disorder model. using A ATOM 69 NE2AHIS 7 14.848 -12.275 10.141 0.50 23.08 N Unresolved disorder model. using A ATOM 70 NE2BHIS 7 16.695 -9.294 11.257 0.50 28.91 N Unresolved disorder model. using A ATOM 143 CA AASP 16 11.581 3.098 17.420 0.50 18.25 C Unresolved disorder model. using A ATOM 144 CA BASP 16 11.602 3.115 17.433 0.50 17.90 C Unresolved disorder model. using A ATOM 147 CB AASP 16 11.029 2.853 16.013 0.50 18.88 C Unresolved disorder model. using A ATOM 148 CB BASP 16 11.119 2.893 15.997 0.50 21.43 C Unresolved disorder model. using A ATOM 149 CG AASP 16 12.081 2.999 14.933 0.50 19.00 C Unresolved disorder model. using A ATOM 150 CG BASP 16 12.222 2.434 15.069 0.50 23.41 C Unresolved disorder model. using A ATOM 151 OD1AASP 16 13.205 3.454 15.260 0.50 22.95 O Unresolved disorder model. using A ATOM 152 OD1BASP 16 13.031 3.278 14.621 0.50 24.45 O Unresolved disorder model. using A ATOM 153 OD2AASP 16 11.797 2.628 13.779 0.50 23.08 O Unresolved disorder model. using A ATOM 154 OD2BASP 16 12.300 1.214 14.792 0.50 29.69 O Unresolved disorder model. using A ATOM 174 CA AILE 19 6.344 3.758 24.737 0.50 12.82 C Unresolved disorder model. using A ATOM 175 CA BILE 19 6.360 3.745 24.748 0.50 12.78 C Unresolved disorder model. using A ATOM 178 CB AILE 19 5.350 4.833 24.274 0.50 12.52 C Unresolved disorder model. using A ATOM 179 CB BILE 19 5.366 4.816 24.284 0.50 13.48 C Unresolved disorder model. using A ATOM 180 CG1AILE 19 4.272 5.235 25.311 0.50 13.45 C Unresolved disorder model. using A ATOM 181 CG1BILE 19 4.240 5.050 25.315 0.50 15.01 C Unresolved disorder model. using A ATOM 182 CG2AILE 19 4.642 4.438 22.983 0.50 13.89 C Unresolved disorder model. using A ATOM 183 CG2BILE 19 4.779 4.497 22.922 0.50 14.40 C Unresolved disorder model. using A ATOM 184 CD1AILE 19 4.857 5.770 26.599 0.50 17.86 C Unresolved disorder model. using A ATOM 185 CD1BILE 19 3.461 6.300 25.009 0.50 15.77 C Unresolved disorder model. using A ATOM 270 CA AASP 31 -9.702 -11.902 32.764 0.50 12.36 C Unresolved disorder model. using A ATOM 271 CA BASP 31 -9.711 -11.901 32.744 0.50 12.18 C Unresolved disorder model. using A ATOM 274 CB AASP 31 -8.712 -11.945 33.897 0.50 15.02 C Unresolved disorder model. using A ATOM 275 CB BASP 31 -8.680 -11.943 33.852 0.50 15.16 C Unresolved disorder model. using A ATOM 276 CG AASP 31 -8.998 -12.896 35.035 0.50 16.24 C Unresolved disorder model. using A ATOM 277 CG BASP 31 -8.838 -13.213 34.663 0.50 15.83 C Unresolved disorder model. using A ATOM 278 OD1AASP 31 -10.171 -13.271 35.288 0.50 21.03 O Unresolved disorder model. using A ATOM 279 OD1BASP 31 -8.298 -14.257 34.255 0.50 22.96 O Unresolved disorder model. using A ATOM 280 OD2AASP 31 -8.022 -13.279 35.732 0.50 20.11 O Unresolved disorder model. using A ATOM 281 OD2BASP 31 -9.540 -13.159 35.708 0.50 23.07 O Unresolved disorder model. using A ATOM 300 CA ATHR 34 -11.176 -10.249 37.727 0.50 19.09 C Unresolved disorder model. using A ATOM 301 CA BTHR 34 -11.267 -10.267 37.859 0.50 19.71 C Unresolved disorder model. using A ATOM 304 CB ATHR 34 -9.677 -10.179 37.367 0.50 17.98 C Unresolved disorder model. using A ATOM 305 CB BTHR 34 -9.739 -10.267 37.972 0.50 21.18 C Unresolved disorder model. using A ATOM 306 OG1ATHR 34 -9.074 -11.443 37.689 0.50 21.60 O Unresolved disorder model. using A ATOM 307 OG1BTHR 34 -9.094 -10.361 36.691 0.50 26.39 O Unresolved disorder model. using A ATOM 308 CG2ATHR 34 -8.993 -9.084 38.164 0.50 19.87 C Unresolved disorder model. using A ATOM 309 CG2BTHR 34 -9.200 -11.483 38.726 0.50 19.98 C Unresolved disorder model. using A ATOM 316 CA ALYS 36 -15.409 -5.783 38.117 0.50 21.33 C Unresolved disorder model. using A ATOM 317 CA BLYS 36 -15.311 -5.553 38.150 0.50 21.47 C Unresolved disorder model. using A ATOM 320 CB ALYS 36 -14.966 -5.146 39.422 0.50 24.46 C Unresolved disorder model. using A ATOM 321 CB BLYS 36 -14.782 -4.469 39.076 0.50 25.78 C Unresolved disorder model. using A ATOM 322 CG ALYS 36 -15.883 -5.428 40.606 0.50 25.62 C Unresolved disorder model. using A ATOM 323 CG BLYS 36 -15.492 -4.120 40.371 0.50 24.76 C Unresolved disorder model. using A ATOM 324 CD ALYS 36 -15.642 -4.371 41.660 0.50 21.61 C Unresolved disorder model. using A ATOM 325 CD BLYS 36 -16.812 -4.770 40.730 0.50 31.84 C Unresolved disorder model. using A ATOM 326 CE ALYS 36 -16.612 -4.450 42.826 0.50 21.41 C Unresolved disorder model. using A ATOM 327 CE BLYS 36 -16.649 -5.910 41.657 0.50 33.48 C Unresolved disorder model. using A ATOM 328 NZ ALYS 36 -17.491 -5.660 42.800 0.50 33.78 N Unresolved disorder model. using A ATOM 329 NZ BLYS 36 -17.678 -6.736 42.290 0.50 29.89 N Unresolved disorder model. using A ATOM 388 CA ALEU 44 -23.162 2.946 25.616 0.50 22.87 C Unresolved disorder model. using A ATOM 389 CA BLEU 44 -23.153 3.050 25.662 0.50 22.86 C Unresolved disorder model. using A ATOM 392 CB ALEU 44 -22.510 1.788 24.877 0.50 27.22 C Unresolved disorder model. using A ATOM 393 CB BLEU 44 -22.265 1.909 25.176 0.50 24.09 C Unresolved disorder model. using A ATOM 394 CG ALEU 44 -21.007 1.662 24.752 0.50 24.78 C Unresolved disorder model. using A ATOM 395 CG BLEU 44 -21.275 2.348 24.116 0.50 20.05 C Unresolved disorder model. using A ATOM 396 CD1ALEU 44 -20.670 0.638 23.667 0.50 23.69 C Unresolved disorder model. using A ATOM 397 CD1BLEU 44 -20.198 3.230 24.759 0.50 24.33 C Unresolved disorder model. using A ATOM 398 CD2ALEU 44 -20.306 2.989 24.487 0.50 25.79 C Unresolved disorder model. using A ATOM 399 CD2BLEU 44 -20.657 1.158 23.400 0.50 28.59 C Unresolved disorder model. using A ATOM 454 CA ATHR 52 -21.020 8.686 5.681 0.50 19.63 C Unresolved disorder model. using A ATOM 455 CA BTHR 52 -20.877 8.922 5.740 0.50 18.42 C Unresolved disorder model. using A ATOM 458 CB ATHR 52 -21.486 9.937 4.962 0.50 21.34 C Unresolved disorder model. using A ATOM 459 CB BTHR 52 -20.763 10.425 5.453 0.50 20.17 C Unresolved disorder model. using A ATOM 460 OG1ATHR 52 -21.054 9.926 3.576 0.50 23.97 O Unresolved disorder model. using A ATOM 461 OG1BTHR 52 -22.068 11.035 5.522 0.50 27.35 O Unresolved disorder model. using A ATOM 462 CG2ATHR 52 -20.946 11.232 5.515 0.50 22.73 C Unresolved disorder model. using A ATOM 463 CG2BTHR 52 -20.238 10.736 4.060 0.50 23.26 C Unresolved disorder model. using A ATOM 626 CA ALYS 73 -22.448 12.409 11.843 0.50 32.35 C Unresolved disorder model. using A ATOM 627 CA BLYS 73 -22.438 12.406 11.834 0.50 32.19 C Unresolved disorder model. using A ATOM 630 CB ALYS 73 -21.868 12.193 10.436 0.50 32.84 C Unresolved disorder model. using A ATOM 631 CB BLYS 73 -21.842 12.185 10.433 0.50 32.80 C Unresolved disorder model. using A ATOM 632 CG ALYS 73 -21.920 13.444 9.576 0.50 35.39 C Unresolved disorder model. using A ATOM 633 CG BLYS 73 -21.969 13.387 9.513 0.50 34.80 C Unresolved disorder model. using A ATOM 634 CD ALYS 73 -22.571 13.172 8.233 0.50 34.22 C Unresolved disorder model. using A ATOM 635 CD BLYS 73 -21.216 13.177 8.211 0.50 34.13 C Unresolved disorder model. using A ATOM 636 CE ALYS 73 -21.909 13.957 7.105 0.50 32.22 C Unresolved disorder model. using A ATOM 637 CE BLYS 73 -21.806 13.978 7.055 0.50 33.14 C Unresolved disorder model. using A ATOM 638 NZ ALYS 73 -22.764 13.977 5.886 0.50 43.77 N Unresolved disorder model. using A ATOM 639 NZ BLYS 73 -20.890 15.060 6.599 0.50 30.08 N Unresolved disorder model. using A ATOM 661 CA ALYS 77 -21.038 8.660 23.727 0.50 15.11 C Unresolved disorder model. using A ATOM 662 CA BLYS 77 -20.829 8.605 23.785 0.50 14.47 C Unresolved disorder model. using A ATOM 665 CB ALYS 77 -22.116 9.746 23.581 0.50 18.07 C Unresolved disorder model. using A ATOM 666 CB BLYS 77 -21.561 9.947 23.741 0.50 17.17 C Unresolved disorder model. using A ATOM 667 CG ALYS 77 -22.049 10.643 22.356 0.50 19.91 C Unresolved disorder model. using A ATOM 668 CG BLYS 77 -23.056 9.828 23.509 0.50 16.84 C Unresolved disorder model. using A ATOM 669 CD ALYS 77 -23.235 11.568 22.239 0.50 23.82 C Unresolved disorder model. using A ATOM 670 CD BLYS 77 -23.757 11.170 23.362 0.50 22.06 C Unresolved disorder model. using A ATOM 671 CE ALYS 77 -23.272 12.537 23.402 0.50 27.91 C Unresolved disorder model. using A ATOM 672 CE BLYS 77 -25.267 10.982 23.454 0.50 25.81 C Unresolved disorder model. using A ATOM 673 NZ ALYS 77 -23.703 13.900 22.989 0.50 42.81 N Unresolved disorder model. using A ATOM 674 NZ BLYS 77 -26.052 12.208 23.119 0.50 37.20 N Unresolved disorder model. using A ATOM 711 CA ATHR 84 -18.618 13.129 22.298 0.50 16.87 C Unresolved disorder model. using A ATOM 712 CA BTHR 84 -18.616 12.936 22.378 0.50 15.84 C Unresolved disorder model. using A ATOM 715 CB ATHR 84 -19.375 14.195 21.476 0.50 19.27 C Unresolved disorder model. using A ATOM 716 CB BTHR 84 -19.716 13.770 21.707 0.50 16.93 C Unresolved disorder model. using A ATOM 717 OG1ATHR 84 -20.619 14.525 22.089 0.50 20.79 O Unresolved disorder model. using A ATOM 718 OG1BTHR 84 -19.210 15.108 21.593 0.50 20.81 O Unresolved disorder model. using A ATOM 719 CG2ATHR 84 -19.733 13.693 20.070 0.50 21.38 C Unresolved disorder model. using A ATOM 720 CG2BTHR 84 -20.993 13.868 22.535 0.50 23.17 C Unresolved disorder model. using A ATOM 934 CA ALYS 110 -8.076 -15.772 20.790 0.50 10.33 C Unresolved disorder model. using A ATOM 935 CA BLYS 110 -8.087 -15.765 20.793 0.50 10.37 C Unresolved disorder model. using A ATOM 938 CB ALYS 110 -6.767 -16.145 20.103 0.50 11.69 C Unresolved disorder model. using A ATOM 939 CB BLYS 110 -6.757 -16.122 20.125 0.50 11.89 C Unresolved disorder model. using A ATOM 940 CG ALYS 110 -5.478 -15.833 20.844 0.50 12.99 C Unresolved disorder model. using A ATOM 941 CG BLYS 110 -5.539 -15.809 20.978 0.50 12.97 C Unresolved disorder model. using A ATOM 942 CD ALYS 110 -4.291 -16.476 20.119 0.50 12.81 C Unresolved disorder model. using A ATOM 943 CD BLYS 110 -4.260 -16.402 20.366 0.50 13.80 C Unresolved disorder model. using A ATOM 944 CE ALYS 110 -2.950 -16.023 20.651 0.50 15.22 C Unresolved disorder model. using A ATOM 945 CE BLYS 110 -3.068 -15.655 20.934 0.50 15.83 C Unresolved disorder model. using A ATOM 946 NZ ALYS 110 -2.637 -16.609 21.985 0.50 14.90 N Unresolved disorder model. using A ATOM 947 NZ BLYS 110 -1.772 -16.356 20.730 0.50 19.27 N Unresolved disorder model. using A ATOM 1077 CA AASP 126 -8.960 17.007 15.126 0.50 15.33 C Unresolved disorder model. using A ATOM 1078 CA BASP 126 -9.252 16.841 15.190 0.50 13.90 C Unresolved disorder model. using A ATOM 1081 CB AASP 126 -7.995 17.722 14.188 0.50 14.46 C Unresolved disorder model. using A ATOM 1082 CB BASP 126 -8.683 17.438 13.929 0.50 14.56 C Unresolved disorder model. using A ATOM 1083 CG AASP 126 -6.594 18.130 14.525 0.50 15.66 C Unresolved disorder model. using A ATOM 1084 CG BASP 126 -7.272 17.957 14.132 0.50 14.48 C Unresolved disorder model. using A ATOM 1085 OD1AASP 126 -5.694 17.302 14.847 0.50 18.61 O Unresolved disorder model. using A ATOM 1086 OD1BASP 126 -6.567 17.731 15.152 0.50 20.64 O Unresolved disorder model. using A ATOM 1087 OD2AASP 126 -6.304 19.358 14.413 0.50 15.61 O Unresolved disorder model. using A ATOM 1088 OD2BASP 126 -6.812 18.648 13.204 0.50 16.90 O Unresolved disorder model. using A ATOM 1222 CA ALYS 145 -15.641 -15.813 15.155 0.50 11.41 C Unresolved disorder model. using A ATOM 1223 CA BLYS 145 -15.668 -15.815 15.166 0.50 12.09 C Unresolved disorder model. using A ATOM 1226 CB ALYS 145 -16.349 -16.509 16.295 0.50 12.50 C Unresolved disorder model. using A ATOM 1227 CB BLYS 145 -16.440 -16.491 16.282 0.50 12.55 C Unresolved disorder model. using A ATOM 1228 CG ALYS 145 -17.857 -16.438 16.289 0.50 13.61 C Unresolved disorder model. using A ATOM 1229 CG BLYS 145 -17.939 -16.329 16.233 0.50 14.84 C Unresolved disorder model. using A ATOM 1230 CD ALYS 145 -18.497 -17.208 17.434 0.50 17.44 C Unresolved disorder model. using A ATOM 1231 CD BLYS 145 -18.665 -16.857 17.454 0.50 19.56 C Unresolved disorder model. using A ATOM 1232 CE ALYS 145 -20.003 -17.116 17.375 0.50 20.31 C Unresolved disorder model. using A ATOM 1233 CE BLYS 145 -19.031 -18.320 17.282 0.50 22.29 C Unresolved disorder model. using A ATOM 1234 NZ ALYS 145 -20.658 -17.666 18.607 0.50 25.59 N Unresolved disorder model. using A ATOM 1235 NZ BLYS 145 -19.356 -18.935 18.603 0.50 32.10 N Unresolved disorder model. using A ATOM 1248 CA ASER 148 -22.471 -18.001 9.726 0.50 18.05 C Unresolved disorder model. using A ATOM 1249 CA BSER 148 -22.471 -17.997 9.730 0.50 16.87 C Unresolved disorder model. using A ATOM 1252 CB ASER 148 -23.857 -17.722 10.301 0.50 19.87 C Unresolved disorder model. using A ATOM 1253 CB BSER 148 -23.850 -17.673 10.296 0.50 19.98 C Unresolved disorder model. using A ATOM 1254 OG ASER 148 -23.832 -16.654 11.234 0.50 25.30 O Unresolved disorder model. using A ATOM 1255 OG BSER 148 -24.448 -18.812 10.880 0.50 22.10 O Unresolved disorder model. using A ATOM 1396 CA ALYS 168 -4.284 1.182 -3.206 0.50 16.32 C Unresolved disorder model. using A ATOM 1397 CA BLYS 168 -4.280 1.205 -3.213 0.50 16.40 C Unresolved disorder model. using A ATOM 1400 CB ALYS 168 -4.634 -0.166 -3.875 0.50 16.73 C Unresolved disorder model. using A ATOM 1401 CB BLYS 168 -4.577 -0.127 -3.939 0.50 16.50 C Unresolved disorder model. using A ATOM 1402 CG ALYS 168 -3.558 -0.676 -4.797 0.50 19.37 C Unresolved disorder model. using A ATOM 1403 CG BLYS 168 -3.603 -0.404 -5.068 0.50 18.58 C Unresolved disorder model. using A ATOM 1404 CD ALYS 168 -3.467 0.136 -6.072 0.50 21.79 C Unresolved disorder model. using A ATOM 1405 CD BLYS 168 -4.085 0.124 -6.394 0.50 22.88 C Unresolved disorder model. using A ATOM 1406 CE ALYS 168 -3.869 -0.735 -7.260 0.50 27.55 C Unresolved disorder model. using A ATOM 1407 CE BLYS 168 -3.380 -0.498 -7.587 0.50 26.27 C Unresolved disorder model. using A ATOM 1408 NZ ALYS 168 -3.464 -0.070 -8.531 0.50 36.25 N Unresolved disorder model. using A ATOM 1409 NZ BLYS 168 -3.688 -1.953 -7.699 0.50 29.76 N Unresolved disorder model. using A ATOM 1764 CA ASER 213 -20.058 -14.367 13.272 0.50 12.87 C Unresolved disorder model. using A ATOM 1765 CA BSER 213 -19.866 -14.341 13.306 0.50 13.01 C Unresolved disorder model. using A ATOM 1768 CB ASER 213 -21.221 -15.364 13.367 0.50 12.95 C Unresolved disorder model. using A ATOM 1769 CB BSER 213 -20.715 -15.581 13.566 0.50 14.29 C Unresolved disorder model. using A ATOM 1770 OG ASER 213 -21.131 -16.084 14.576 0.50 16.49 O Unresolved disorder model. using A ATOM 1771 OG BSER 213 -21.974 -15.386 12.954 0.50 24.78 O Unresolved disorder model. using A ATOM 1786 CA ASER 216 -14.960 -18.910 6.480 0.50 16.89 C Unresolved disorder model. using A ATOM 1787 CA BSER 216 -14.968 -18.913 6.473 0.50 16.63 C Unresolved disorder model. using A ATOM 1790 CB ASER 216 -14.774 -20.421 6.362 0.50 18.90 C Unresolved disorder model. using A ATOM 1791 CB BSER 216 -14.861 -20.431 6.365 0.50 18.22 C Unresolved disorder model. using A ATOM 1792 OG ASER 216 -15.754 -20.990 5.505 0.50 20.96 O Unresolved disorder model. using A ATOM 1793 OG BSER 216 -13.529 -20.823 6.142 0.50 21.55 O 1